arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

EXICURE, INC.

XCUR
$1.29 ▼ -0.03 (-2.26%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
11 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

EXICURE, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $8.1M
Dividend Yield
Revenue Growth N/M
Op. Margin None
ROIC -95.6%
FCF / Share $-1.36
Trailing P/E
Price / Book 2.1x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-4.95M
↑ +49.0%
Operating Margin Operating profit as % of sales
-6.4%
↑ +95.9%
FCF / Share Free cash flow per share
$-1.36
↑ +4.6%
Long-Term Debt Long-term obligations
$6.87M
↓ -58.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
6
Cash Quality
83

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 40 quarters